View Cart  
Fdanewsdrugdailybulletin

Jan. 27, 2005

Vol. 2 No. 19

View Archived Issues

Sign Up Now

Public Confidence in Drug Companies Declining, Poll Shows

The mounting safety concerns swirling around the pharmaceutical industry are beginning to have a profound effect on the American public's perception of drug companies, according to a recent online poll.

Read More

FDA Warns Lex Pharmaceutical for cGMP Violations

Drugmaker Lex Pharmaceutical has been issued a warning letter following an FDA inspection that revealed a slew of manufacturing violations at the company's Medley, Fla., plant.

Read More

Enzi Supports Drug Importation If Security, Cost Issues Resolved

The new chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee said he would support legislation allowing the importation of pharmaceuticals into the U.S., but noted that such a plan could conflict with the mission of the FDA.

Read More

More Questions About Cox-2 Safety Arises From New Research

Two new clinical studies provide further evidence that the use of anti-inflammatory Cox-2 inhibitor drugs could increase the risk of serious cardiovascular events in humans.

Read More

MorphoSys, Bristol-Myers Squibb Extend Cooperation

German biotech MorphoSys AG is expanding its existing license agreement with Bristol-Myers Squibb.

Read More

AEterna Zentaris Subsidiary Atrium Biotechnologies Acquires Canadian Business Multichem

AEterna Zentaris has announced the closing of the acquisition of all Multichem assets by its subsidiary Atrium Biotechnologies for the total amount of $23.8 million of which $22.2 million were paid in cash at the closing.

Read More

British Biotech Company Moving to Boulder

Sciona, a private, international biotechnology company, is moving its headquarters from the UK to Boulder, Colo. Jim Bruce, a Boulder businessman, has been named CEO.

Read More

Applied DNA Sciences Receives $5,482,993 Million in Funding

Applied DNA Sciences has reported that its managing investment banker, New York-based Vertical Capital Partners along with participation from other funds and investors, has closed on $5,482,993 of funding for APDN.

Read More

Pall Acquires Euroflow

Pall has acquired Euroflow (UK) of Stroud, England. The company is one of the world's leading manufacturers of pilot and production scale chromatography columns for the biotechnology industry.

Read More

PDL's Buyout of ESP Pharma: $475 Million for Drugs, Sales Team

Protein Design Labs has agreed to buy the hospital-focused pharmaceutical firm ESP Pharma for $300 million in cash and roughly $175 million in stock, thereby gaining marketed products, a 75-person sales force, entry into the cardiac field -- and approximately $14 million in ESP debt.

Read More

Millennium Pharma, Belgian Firm Forge Collaboration

Millennium Pharmaceuticals will collaborate with a Belgium pharmaceutical giant to develop potential inflammation treatments.

Read More

Genaissance Obtains License to Vanderbilt Patent

Genaissance Pharmaceuticals, a leading developer and user of genetic information to help guide medical therapy, expanded its ability to provide genetic tests for critical variants of key cardiac ion channel proteins involved in drug-induced cardiac arrhythmias.

Read More

Genetronics Acquires Inovio AS

Genetronics Biomedical, a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, has announced the acquisition of Oslo-based Inovio AS, a leader in patented gene delivery technology for the most efficient, nonviral method for gene transfer to skeletal muscles.

Read More